ArticleCureus2025

The Pretreatment Neutrophil-to-Eosinophil Ratio Can Predict Immune-Related Adverse Events and Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.

Keita Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.